HOME >> MEDICINE >> NEWS
Major study: Bioartificial liver reduces mortality by 44 percent in acute liver-failure patients

LOS ANGELES(EMBARGOED UNTIL APRIL 22, 2004) In a major study conducted at 20 centers in the United States and Europe, a bioartificial liver developed by researchers at Cedars-Sinai Medical Center reduced mortality significantly among patients suffering from acute liver failure, the dramatic loss of liver function that can cause death in days or even hours. Study results are published in the May issue of Annals of Surgery.

This is the first large-scale, prospective, randomized, multi-center trial examining the effectiveness of any artificial liver support. Currently, standard treatment consists of intensive, supportive care intended to keep patients alive long enough that the liver might recover spontaneously or a donor organ will become available for transplantation.

Acute liver failure is diagnosed when a massive loss of hepatic cells causes severe liver dysfunction and life-threatening complications within six months of the onset of symptoms. When this dysfunction occurs within the first eight weeks after onset, liver failure is termed "fulminant." When it occurs in the period between eight weeks and six months, it is "subfulminant" (or late-onset). In either case, few patients survive the resulting fluid buildup in the brain, catastrophic bacterial infections, multi-organ failure, blood-clotting abnormalities, respiratory problems, kidney failure or other potential complications. It is estimated, in fact, that up to 80 percent of patients will die unless they receive a liver transplant.

In the United States, the causes of many cases of acute liver failure are never identified, although precipitating factors can include toxic poisoning, medication interactions or overdoses, metabolic disorders, and some types of viral hepatitis.

Achilles A. Demetriou, MD, PhD, Chairman of Surgery at Cedars-Sinai and the study's principal investigator, has been pursuing treatments for acute liver diseases since 1976 when he began studying liver cel
'"/>

Contact: Sandra Van
sandy@vancommunications.com
1-800-880-2397
Cedars-Sinai Medical Center
22-Apr-2004


Page: 1 2 3

Related medicine news :

1. Major review of subway systems suggests potential for significant health and safety hazards
2. Major step forwards for vaccine against cervical cancer
3. Majority of cigarettes in the US smoked by nicotine-dependent or psychiatrically ill persons
4. Major overhaul needed in end-of life care for patients with dementia
5. Major overhaul needed in end-of life care for patients with dementia
6. Major radiology journal offers unrestricted access to recently archived articles
7. Majority of authors retract 1998 Lancet paper-Lancet editor points to implications
8. Major agreement reached at heart health conference
9. Major risk factors identified for sudden infant death syndrome
10. Major cause of painful gastroenteritis under study at MCG
11. Major advance in chemotherapy in breast cancer

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/5/2020)... ... August 05, 2020 , ... In its often-heroic ... unprecedented challenges. Regardless of the obstacle - shortages of tests, ventilators and ICU ... the cancellation or postponement of all nonessential services - providers across the country ...
(Date:8/5/2020)... ... ... CentrAlert, Inc. today announced the launch of their free ... NOW!, which is available for Apple and Android , seeks to ... application. , “When COVID-19 first hit, there was so much that we didn’t know,” ...
(Date:8/5/2020)... ... 04, 2020 , ... Today, Power to Decide’s One Key Question ... 2020 Innovation Station Best Practice Award. The One Key Question program is a transformative ... pregnant and have a child. One Key Question is used by thousands of health ...
(Date:8/3/2020)... CHICAGO and FORT WORTH, Texas (PRWEB) , ... ... ... clinical stage biopharmaceutical company, today announced enrollment of the first patients with first-line ... arm of the ongoing phase 1/2 1801 trial of 9-ING-41, (NCT03678883, EudraCT#:2018-003739-32). ...
(Date:7/31/2020)... ... 2020 , ... National Association of Chain Drug Stores (NACDS) ... nation’s ongoing preparations for the eventual deployment of COVID-19 vaccines: , “By any ... essential component of vaccine deployment. They will need to be part of the ...
Breaking Medicine News(10 mins):
(Date:7/10/2020)... (PRWEB) , ... July 10, ... ... , the leading review of business and technology for the pharmaceutical industry ... development and manufacturing of the highest quality pharmaceutical products. QC Corner ...
(Date:7/7/2020)... ... 07, 2020 , ... Nonprofit Team PHenomenal Hope (Team PH) will announce the ... first ever virtual research town hall on Saturday, July 11 at noon EST. In ... research in the area of pulmonary hypertension (PH), in focused talks geared toward the ...
(Date:7/7/2020)... ... July 07, 2020 , ... ... to Navajo Nation residents, the 33 nonprofits who received the latest ISA ... fourth round of funding, the foundation awarded grants totaling $838,527 to the U.S.-based ...
Breaking Medicine Technology:
Cached News: